Kupryjanczyk: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Two subtypes of serous ovarian cancer with different gene expression pattern

K. Lisowska, M. Olbryt, M. Jarzab, K. Simek, E. Nowara, J. Kupryjanczyk

Journal:

New Biotechnology

Year:

2010

Language:

english

File:

PDF, 78 KB

english, 2010

2

10. Kliniczne znaczenie zmian molekularnych w raku jajnika

J. Kupryjańczyk

Journal:

Reports of Practical Oncology & Radiotherapy

Year:

2003

Language:

polish

File:

PDF, 207 KB

polish, 2003

3

Clinical value of molecular changes in ovarian carcinoma

Jolanta Kupryjańczyk

Journal:

Reports of Practical Oncology & Radiotherapy

Year:

2004

File:

PDF, 185 KB

2004

4

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours

J. PLISIECKA-HAŁASA, A. DANSONKA-MIESZKOWSKA, A. REMBISZEWSKA, M. BIDZIŃSKI, J. STEFFEN, J. KUPRYJAŃCZYK

Journal:

Annals of Human Genetics

Year:

2002

Language:

english

File:

PDF, 376 KB

english, 2002

5

Signet-ring cells in squamous cell carcinoma of the cervix and in non-neoplastic ectocervical epithelium

J. Kupryjańczyk, M. Kujawa

Journal:

International Journal of Gynecological Cancer

Year:

1992

Language:

english

File:

PDF, 6.41 MB

english, 1992

6

A novel germlinePALB2deletion in Polish breast and ovarian cancer patients

Agnieszka Dansonka-Mieszkowska, Anna Kluska, Joanna Moes, Michalina Dabrowska, Dorota Nowakowska, Anna Niwinska, Pawel Derlatka, Krzysztof Cendrowski, Jolanta Kupryjanczyk

Journal:

BMC Medical Genetics

Year:

2010

Language:

english

File:

PDF, 1.05 MB

english, 2010

7

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

Anna Felisiak-Golabek, Alina Rembiszewska, Iwona K Rzepecka, Lukasz Szafron, Radoslaw Madry, Magdalena Murawska, Tomasz Napiorkowski, Piotr Sobiczewski, Beata Osuch, Jolanta Kupryjanczyk, the Polish O

Journal:

Journal of Ovarian Research

Year:

2011

Language:

english

File:

PDF, 285 KB

english, 2011

8

Cycle- and function-related changes in lectin binding to human endometrium: a histochemical study with pronase treatment

J. Kupryjańczyk

Journal:

Archives of Gynecology and Obstetrics

Year:

1989

Language:

english

File:

PDF, 1.81 MB

english, 1989

9

P27Kip1and Ki-67 expression analysis in transitional cell carcinoma of the bladder

Bartosz Dybowski, Jolanta Kupryjańczyk, Alina Rembiszewska, Roman Pykało, Andrzej Borkowski

Journal:

Year:

2003

Language:

english

File:

PDF, 230 KB

english, 2003

10

NANOS1 and PUMILIO2 bind microRNA biogenesis factor GEMIN3, within chromatoid body in human germ cells

Barbara Ginter-Matuszewska, Kamila Kusz, Anna Spik, Dominika Grzeszkowiak, Alina Rembiszewska, Jolanta Kupryjanczyk, Jadwiga Jaruzelska

Journal:

Histochemistry and Cell Biology

Year:

2011

Language:

english

File:

PDF, 987 KB

english, 2011

11

Geographical Variations in TP53 Mutational Spectrum in Ovarian Carcinomas

A. Dansonka-Mieszkowska, A. H. Ludwig, E. Kraszewska, J. Kupryjańczyk

Journal:

Annals of Human Genetics

Year:

2006

Language:

english

File:

PDF, 226 KB

english, 2006

12

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

Kupryjańczyk, J, Mądry, R, Plisiecka-Hałasa, J, Bar, J, Kraszewska, E, Ziółkowska, I, Timorek, A, Stelmachów, J, Emerich, J, Jędryka, M

Journal:

British Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 187 KB

english, 2004

13

CHFR gene is neither mutated nor hypermethylated in ovarian cancer

Agnieszka H. Ludwig, Mateusz Bujko, Mariusz Bidzinski, Jolanta Kupryjańczyk

Journal:

Cancer Detection and Prevention

Year:

2007

Language:

english

File:

PDF, 228 KB

english, 2007

14

Why TP53 status does not associate with clinical endpoints in ovarian cancer: Facts and hypotheses

Jolanta Kupryjańczyk

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 79 KB

english, 2006

15

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations

I.K. Kolasa, A. Rembiszewska, A. Janiec-Jankowska, A. Dansonka-Mieszkowska, A.M. Lewandowska, B. Konopka, J. Kupryjańczyk

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 355 KB

english, 2006

16

TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens

Izabela Ziółkowska-Seta, Radosław Mądry, Ewa Kraszewska, Teresa Szymańska, Agnieszka Timorek, Alina Rembiszewska, Jolanta Kupryjańczyk

Journal:

Gynecologic Oncology

Year:

2009

Language:

english

File:

PDF, 170 KB

english, 2009

17

HAX-1 overexpression, splicing and cellular localization in tumors

Alicja Trebinska, Alina Rembiszewska, Karolina Ciosek, Konrad Ptaszynski, Sebastian Rowinski, Jolanta Kupryjanczyk, Janusz A Siedlecki, Ewa A Grzybowska

Journal:

Year:

2010

Language:

english

File:

PDF, 2.45 MB

english, 2010

18

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study

Jolanta Kupryjanczyk, Ewa Kraszewska, Izabela Ziolkowska-Seta, Radoslaw Madry, Agnieszka Timorek, Janina Markowska, Jerzy Stelmachow, Mariusz Bidzinski, The Polish Ovarian Cancer Study Group (POCSG)

Journal:

Year:

2008

Language:

english

File:

PDF, 374 KB

english, 2008

19

Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer

Piotr Bragoszewski, Jolanta Kupryjanczyk, Ewa Bartnik, Andrea Rachinger, Jerzy Ostrowski

Journal:

Year:

2008

Language:

english

File:

PDF, 397 KB

english, 2008

20

High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations

Iwona K. Rzepecka, Lukasz Szafron, Agnieszka Stys, Mateusz Bujko, Joanna Plisiecka-Halasa, Radoslaw Madry, Beata Osuch, Janina Markowska, Mariusz Bidzinski, Jolanta Kupryjanczyk

Journal:

Cancer Genetics

Year:

2012

Language:

english

File:

PDF, 133 KB

english, 2012

21

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland

A. Bardin, S. Vaccarella, G.M. Clifford, J. Lissowska, M. Rekosz, P. Bobkiewicz, J. Kupryjańczyk, R. Krynicki, J. Jonska-Gmyrek, A. Danska-Bidzinska, P.J.F. Snijders, C.J.L.M. Meijer, W. Zatonski, S.

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 166 KB

english, 2008

22

223 Thrombospondin 2 Gene (THBS2) and Its Role in Ovarian Cancer

A. Cortez, K. Kujawa, M. Olbryt, J. Kupryjanczyk, K. Lisowska

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 55 KB

english, 2012

23

273 MiR-7 Expression Depends on TP53 Mutational Status in Primary Serous Ovarian Cancer

A. Swiercz, A. Dansonka-Mieszkowska, K. Goryca, M. Kulinczak, M. Zajdel, M. Chechlinska, A. Rembiszewska, J. Kupryjanczyk, J.K. Siwicki

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 73 KB

english, 2012

24

543 Aberrant Methylation of the BRCA1 Promoter in Ovarian Cancers

I.K. Rzepecka, M. Bujko, L. Szafron, J. Plisiecka-Halasa, A. Felisiak-Golabek, J. Kupryjanczyk

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 72 KB

english, 2012

25

Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample

Anna Lorenc, Jarosław Bryk, Paweł Golik, Jolanta Kupryjańczyk, Jerzy Ostrowski, Maciej Pronicki, Andrzej Semczuk, Małgorzata Szołkowska, Ewa Bartnik

Journal:

Year:

2003

Language:

english

File:

PDF, 108 KB

english, 2003

26

741 microRNA-34 expression and the status of TP53 in the primary ovarian cancer

A. Swiercz, J.K. Siwicki, M. Chechlinska, M. Zajdel, A. Dansonka-Mieszkowska, A. Rembiszewska, J. Kupryjanczyk

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

27

MC13-0045 Genes from the TP53 network and their role in ovarian cancer prognosis and response to chemotherapy

Podgorska, A., Szafron, L., Felisiak-Golabek, A., Kupryjanczyk, J.

Journal:

European Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 114 KB

english, 2013

28

434 A Poor Predictor in Ovarian Cancer Patients Treated with Taxane–Platinum Regimen

Felisiak-Golabek, A., Rembiszewska, A., Szafron, L., Chodzynska, J., Kwiatkowska, E., Rzepecka, I., Dansonka-Mieszkowska, A., Podgorska, A., Kupryjanczyk, J.

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 62 KB

english, 2012

29

447 14-3-3sigma Protein Expression and Its Predictive Value in Ovarian Cancer

Podgorska, A., Felisiak-Golabek, A., Rembiszewska, A., Szafron, L., Kupryjanczyk, J.

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

30

631: Impact of TP53 accumulation on ovarian cancer prognosis in BRCA1 mutation carriers

Rzepecka, I.K., Szafron, L., Felisiak-Golabek, A., Podgorska, A., Kupryjanczyk, J.

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 81 KB

english, 2014

31

p19 INK4d mRNA and protein expression as new prognostic factors in ovarian cancer patients

Felisiak-Golabek, Anna, Dansonka-Mieszkowska, Agnieszka, Rzepecka, Iwona K, Szafron, Lukasz, Kwiatkowska, Ewa, Konopka, Bozena, Podgorska, Agnieszka, Rembiszewska, Alina, Kupryjanczyk, Jolanta

Journal:

Cancer Biology & Therapy

Year:

2013

Language:

english

File:

PDF, 1.00 MB

english, 2013

32

Does MDR-1 G2677T/A Polymorphism Really Associate with Ovarian Cancer Response to Paclitaxel Chemotherapy?

Ludwig, A. H., Kupryjanczyk, J.

Journal:

Clinical Cancer Research

Year:

2006

Language:

english

File:

PDF, 91 KB

english, 2006

33

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

Kupryjańczyk, J, Szymańska, T, Mądry, R, Timorek, A, Stelmachów, J, Karpińska, G, Rembiszewska, A, Ziółkowska, I, Kraszewska, E, Dębniak, J, Emerich, J, Ułańska, M, Płużańska, A, Jędryka, M, Goluda, M

Journal:

British Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 135 KB

english, 2003

34

Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

Lee, Alice W., Tyrer, Jonathan P., Doherty, Jennifer A., Stram, Douglas A., Kupryjanczyk, Jolanta, Dansonka-Mieszkowska, Agnieszka, Plisiecka-Halasa, Joanna, Spiewankiewicz, Beata, Myers, Emily J., Ch

Journal:

Gynecologic Oncology

Year:

2015

Language:

english

File:

PDF, 299 KB

english, 2015

35

Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome

Ludwig, A. H., Murawska, M., Panek, G., Timorek, A., Kupryjanczyk, J.

Journal:

Endocrine Related Cancer

Year:

2009

Language:

english

File:

PDF, 266 KB

english, 2009

36

PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients

Kolasa, Iwona K., Rembiszewska, Alina, Felisiak, Anna, Ziolkowska-Seta, Izabela, Murawska, Magdalena, Moes, Joanna, Timorek, Agnieszka, Dansonka-Mieszkowska, Agnieszka, Kupryjanczyk, Jolanta

Journal:

Cancer Biology & Therapy

Year:

2009

Language:

english

File:

PDF, 905 KB

english, 2009

37

The SNARE-associated component SNAPIN binds PUMILIO2 and NANOS1 proteins in human male germ cells

Ginter-Matuszewska, B., Spik, A., Rembiszewska, A., Koyias, C., Kupryjanczyk, J., Jaruzelska, J.

Journal:

Molecular Human Reproduction

Year:

2009

Language:

english

File:

PDF, 426 KB

english, 2009

38

p53 Gene Mutations and Protein Accumulation in Human Ovarian Cancer

Jolanta Kupryjanczyk, Ann D. Thor, Roberta Beauchamp, Victor Merritt, Susan M. Edgerton, Debra A. Bell and David W. Yandell

Journal:

Proceedings of the National Academy of Sciences

Year:

1993

Language:

english

File:

PDF, 1.09 MB

english, 1993

39

448 Clinical significance of HUWE1 expression in ovarian cancer

Podgorska, A., Rembiszewska, A., Szafron, L., Konopka, B., Lukasik, M., Budzilowska, A., Kupryjanczyk, J.

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 62 KB

english, 2015

40

p53 Expression in Ovarian Borderline Tumors and Stage I Carcinomas

Kupryjańczyk, Jolanta, Bell, Debra A., Yandell, David W., Scully, Robert E., Thor, Ann D.

Journal:

American Journal of Clinical Pathology

Year:

1994

Language:

english

File:

PDF, 2.51 MB

english, 1994

41

The Evaluation of Risk Factors Associated With Relapse and Recurrence of Borderline Ovarian Tumors With Long-Term Follow-up

Sobiczewski, Piotr, Kupryjanczyk, Jolanta, Michalski, Wojciech, Śpiewankiewicz, Beata

Journal:

International Journal of Gynecological Cancer

Year:

2016

Language:

english

File:

PDF, 196 KB

english, 2016

42

p53 gene mutations and protein accumulation in human ovarian cancer.

Kupryjanczyk, J., Thor, A. D., Beauchamp, R., Merritt, V., Edgerton, S. M., Bell, D. A., Yandell, D. W.

Journal:

Proceedings of the National Academy of Sciences

Year:

1993

Language:

english

File:

PDF, 1.25 MB

english, 1993

43

Epidermal Growth Factor Receptor Expression in the Normal and Inflamed Cervix Uteri: A Comparison with Estrogen Receptor Expression

Kupryjańczyk, Jolanta

Journal:

International Journal of Gynecological Pathology

Year:

1990

File:

PDF, 546 KB

1990

44

Estrogen Receptor Distribution in the Normal and Pathologically Changed Human Cervix Uteri

Kupryjańczyk, Jolanta, Möller, Peter

Journal:

International Journal of Gynecological Pathology

Year:

1988

File:

PDF, 741 KB

1988

45

Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells

Rzepecka, Iwona K., Szafron, Lukasz M., Stys, Agnieszka, Felisiak-Golabek, Anna, Podgorska, Agnieszka, Timorek, Agnieszka, Sobiczewski, Piotr, Pienkowska-Grela, Barbara, El-Bahrawy, Mona, Kupryjanczyk

Journal:

Gynecologic Oncology

Year:

2017

Language:

english

File:

PDF, 825 KB

english, 2017

46

Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4 gene inactivation. a pilot study

Kupryjańczyk, Jolanta, Dansonka-Mieszkowska, Agnieszka, Moes-Sosnowska, Joanna, Plisiecka-Hałasa, Joanna, Szafron, Łukasz, Podgórska, Agnieszka, Rzepecka, Iwona K., Konopka, Bożena, Budziłowska, Agnie

Journal:

Polish Journal of Pathology

Year:

2013

Language:

english

File:

PDF, 2.57 MB

english, 2013

47

The genetic landscape of 87 ovarian germ cell tumors

Van Nieuwenhuysen, Els, Busschaert, Pieter, Neven, Patrick, Han, Sileny N., Moerman, Philippe, Liontos, Michalis, Papaspirou, Maria, Kupryjanczyk, Jolanta, Hogdall, Claus, Hogdall, Estrid, Oaknin, Ana

Journal:

Gynecologic Oncology

Year:

2018

Language:

english

File:

PDF, 956 KB

english, 2018

48

Cyclooxygenase-2 immunohistochemical expression in serrated polyps of the colon

Kiedrowski, Miroslaw, Mroz, Andrzej, Kraszewska, Ewa, Rembiszewska, Alina, Felisiak-Golabek, Anna, Kupryjanczyk, Jolanta, Deptala, Andrzej, Orlowska, Janina

Journal:

Współczesna Onkologia

Year:

2014

Language:

english

File:

PDF, 96 KB

english, 2014

49

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas

Moes-Sosnowska, Joanna, Rzepecka, Iwona K., Chodzynska, Joanna, Dansonka-Mieszkowska, Agnieszka, Szafron, Lukasz M., Balabas, Aneta, Lotocka, Renata, Sobiczewski, Piotr, Kupryjanczyk, Jolanta

Journal:

Cancer Biology & Therapy

Year:

2019

File:

PDF, 3.46 MB

2019

50

Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer

Kujawa, Katarzyna Aleksandra, Zembala-Nożyńska, Ewa, Cortez, Alexander Jorge, Kujawa, Tomasz, Kupryjańczyk, Jolanta, Lisowska, Katarzyna Marta

Journal:

Year:

2020

Language:

english

File:

PDF, 12.36 MB

english, 2020